table of content
1 Introduction to Research & Analysis Reports
1.1 RNA-Targeted Small Molecule Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global RNA-Targeted Small Molecule Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA-Targeted Small Molecule Drugs Overall Market Size
2.1 Global RNA-Targeted Small Molecule Drugs Market Size: 2022 VS 2029
2.2 Global RNA-Targeted Small Molecule Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA-Targeted Small Molecule Drugs Players in Global Market
3.2 Top Global RNA-Targeted Small Molecule Drugs Companies Ranked by Revenue
3.3 Global RNA-Targeted Small Molecule Drugs Revenue by Companies
3.4 Top 3 and Top 5 RNA-Targeted Small Molecule Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies RNA-Targeted Small Molecule Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Players in Global Market
3.6.1 List of Global Tier 1 RNA-Targeted Small Molecule Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA-Targeted Small Molecule Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global RNA-Targeted Small Molecule Drugs Market Size Markets, 2022 & 2029
4.1.2 mRNA Translation Regulation
4.1.3 RNA Splicing Modification
4.1.4 Direct RNA Targeting
4.1.5 Indirect RNA Targeting - Epitranscriptomics
4.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
4.2.1 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
4.2.2 By Type - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
4.2.3 By Type - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global RNA-Targeted Small Molecule Drugs Market Size, 2022 & 2029
5.1.2 SMA
5.1.3 Oncology
5.1.4 Lung Fibrosis
5.1.5 Huntington's Disease
5.1.6 Others
5.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
5.2.1 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
5.2.2 By Application - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
5.2.3 By Application - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global RNA-Targeted Small Molecule Drugs Market Size, 2022 & 2029
6.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue & Forecasts
6.2.1 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2018-2023
6.2.2 By Region - Global RNA-Targeted Small Molecule Drugs Revenue, 2024-2029
6.2.3 By Region - Global RNA-Targeted Small Molecule Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.3.2 US RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.3.3 Canada RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.3.4 Mexico RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.4.2 Germany RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.3 France RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.4 U.K. RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.5 Italy RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.6 Russia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.7 Nordic Countries RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.4.8 Benelux RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.5.2 China RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.3 Japan RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.4 South Korea RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.5 Southeast Asia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.5.6 India RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.6.2 Brazil RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.6.3 Argentina RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA-Targeted Small Molecule Drugs Revenue, 2018-2029
6.7.2 Turkey RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7.3 Israel RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
6.7.5 UAE RNA-Targeted Small Molecule Drugs Market Size, 2018-2029
7 RNA-Targeted Small Molecule Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche RNA-Targeted Small Molecule Drugs Major Product Offerings
7.1.4 Roche RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Novartis
7.2.1 Novartis Company Summary
7.2.2 Novartis Business Overview
7.2.3 Novartis RNA-Targeted Small Molecule Drugs Major Product Offerings
7.2.4 Novartis RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.2.5 Novartis Key News & Latest Developments
7.3 PTC Therapeutics
7.3.1 PTC Therapeutics Company Summary
7.3.2 PTC Therapeutics Business Overview
7.3.3 PTC Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.3.4 PTC Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.3.5 PTC Therapeutics Key News & Latest Developments
7.4 Biogen
7.4.1 Biogen Company Summary
7.4.2 Biogen Business Overview
7.4.3 Biogen RNA-Targeted Small Molecule Drugs Major Product Offerings
7.4.4 Biogen RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.4.5 Biogen Key News & Latest Developments
7.5 Accent Therapeutics
7.5.1 Accent Therapeutics Company Summary
7.5.2 Accent Therapeutics Business Overview
7.5.3 Accent Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.5.4 Accent Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.5.5 Accent Therapeutics Key News & Latest Developments
7.6 Anima Biotech
7.6.1 Anima Biotech Company Summary
7.6.2 Anima Biotech Business Overview
7.6.3 Anima Biotech RNA-Targeted Small Molecule Drugs Major Product Offerings
7.6.4 Anima Biotech RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.6.5 Anima Biotech Key News & Latest Developments
7.7 Arrakis Pharmaceuticals
7.7.1 Arrakis Pharmaceuticals Company Summary
7.7.2 Arrakis Pharmaceuticals Business Overview
7.7.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Major Product Offerings
7.7.4 Arrakis Pharmaceuticals RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.7.5 Arrakis Pharmaceuticals Key News & Latest Developments
7.8 Epics Therapeutics
7.8.1 Epics Therapeutics Company Summary
7.8.2 Epics Therapeutics Business Overview
7.8.3 Epics Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.8.4 Epics Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.8.5 Epics Therapeutics Key News & Latest Developments
7.9 Expansion Therapeutics
7.9.1 Expansion Therapeutics Company Summary
7.9.2 Expansion Therapeutics Business Overview
7.9.3 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.9.4 Expansion Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.9.5 Expansion Therapeutics Key News & Latest Developments
7.10 Gotham Therapeutics
7.10.1 Gotham Therapeutics Company Summary
7.10.2 Gotham Therapeutics Business Overview
7.10.3 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.10.4 Gotham Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.10.5 Gotham Therapeutics Key News & Latest Developments
7.11 H3 Biomedicine
7.11.1 H3 Biomedicine Company Summary
7.11.2 H3 Biomedicine Business Overview
7.11.3 H3 Biomedicine RNA-Targeted Small Molecule Drugs Major Product Offerings
7.11.4 H3 Biomedicine RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.11.5 H3 Biomedicine Key News & Latest Developments
7.12 Ribometrix
7.12.1 Ribometrix Company Summary
7.12.2 Ribometrix Business Overview
7.12.3 Ribometrix RNA-Targeted Small Molecule Drugs Major Product Offerings
7.12.4 Ribometrix RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.12.5 Ribometrix Key News & Latest Developments
7.13 Skyhawk Therapeutics
7.13.1 Skyhawk Therapeutics Company Summary
7.13.2 Skyhawk Therapeutics Business Overview
7.13.3 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.13.4 Skyhawk Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.13.5 Skyhawk Therapeutics Key News & Latest Developments
7.14 STORM Therapeutics
7.14.1 STORM Therapeutics Company Summary
7.14.2 STORM Therapeutics Business Overview
7.14.3 STORM Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.14.4 STORM Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.14.5 STORM Therapeutics Key News & Latest Developments
7.15 Twentyeight-Seven Therapeutics
7.15.1 Twentyeight-Seven Therapeutics Company Summary
7.15.2 Twentyeight-Seven Therapeutics Business Overview
7.15.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Major Product Offerings
7.15.4 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecule Drugs Revenue in Global Market (2018-2023)
7.15.5 Twentyeight-Seven Therapeutics Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
